ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2014, Vol. 23 ›› Issue (1): 23-30.

• 论文 • 上一篇    下一篇

嗜酸性肉芽肿性血管炎肾损害的临床病理特征及预后

  

  • 出版日期:2014-02-28 发布日期:2014-02-25

Clinic-pathological features and outcomes of patients with eosinophilic granulomatosis with polyangiitis and renal involvement

  • Online:2014-02-28 Published:2014-02-25

摘要:

摘 要 目的:回顾性分析嗜酸性肉芽肿性血管炎肾损害的临床病理特征及转归。 方法: 14例嗜酸性肉芽肿性血管炎(EGPA)伴肾脏损害的患者[女性8例 ,男性6例 ,年龄20-70岁,病程1~600月(中位病程120月)],均行肾活检术,有完整的临床病理资料。回顾性分析其临床病理特征及预后。 结果:14例EGPA占同期ANCA相关血管炎的6.76%。所有患者血清ANCA阳性,以p-/MPO-ANCA为主(占85.7%)。哮喘(57.1%)为最常见的首发症状,其它首发症状分别为咯血(n=3)、肉眼血尿(n=2)和关节炎(n=1)。外周血嗜酸性粒细胞比例均增高(10%~45%,平均18.14%土9.78%)伴血清IgE水平升高(平均541土462g/L)。除1例无蛋白尿和血尿外,其余13例均存在蛋白尿和血尿,尿蛋白2.90±3.53g/24h,其中5例(35%)表现为肾病综合征,2例为肉眼血尿。患者均存在肾功能不全,平均SCr 498.6±288.6 ?mol/L,其中7例(50%)需肾脏替代治疗。肾活检病理1例为急性间质性肾炎,其余13例为节段坏死性肾小球肾炎伴新月体形成,病理类型分别为混合型6例,新月体型4例,局灶型2例,硬化型1例。12例(85.7%)肾组织见嗜酸性粒细胞浸润,其中3例为嗜酸性粒细胞肉芽肿。患者均接受激素或联合免疫抑制药物治疗,7例需肾脏替代治疗的患者中5例肾功能改善并摆脱透析,1例进入维持性透析,1例死亡。12例患者随访6~83月(中位时间43.5月),1例进展为终末期肾病,9例慢性肾功能不全,2例尿检和SCr正常。1例出现肾外复发。 结论: 本组嗜酸性肉芽肿性血管炎肾脏损害重,肾脏病理改变多样,积极免疫抑制治疗能有效改善肾功能,但总体肾脏预后较差。需要早期诊断和积极治疗以改善肾脏远期预后。

关键词: 嗜酸性肉芽肿性血管炎, 肾脏损害, 抗中性粒细胞胞质抗体, 抗中性粒细胞胞质抗体相关血管炎

Abstract:

ABSTRACT Objective: To investigate the clinic-pathological features and outcomes of patients with eosinophilic granulomatosis with polyangiitis and renal involvement. Methodology: Fourteen patients diagnosed as eosinophilic granulomatosis with polyangiitis (EGPA) were investigated in this retrospective study. All of them had renal involvement and were performed renal biopsy. Their clinic-pathological features and outcomes were analyzed. Results: They were 8 female and 6 male with age from 20 to 70 years old, and the vasculitis duration from 1~600 months. They accounted for 6.76% of all ANCA associated vasculitis in the same period in our hospital .All patients had positive serum ANCA, among them, 12(85.7%)were p-/MPO-ANCA. The most common onset symptom was asthma (57.1%, n=8),the others were hemoptysis (21.4%, n=3)、gross hematuria(14.3%, n=2)and arthritis (7.14%, n=1). All patients had increased peripheral eosinophil ratio from 10% to 45% with the average of 18.1±9.8%) accompanied with elevated serum IgE levels of 541± 462g/l. Except one, the other 13 patients had both hematuria and proteinuria. The mean urine protein was 2.90±3.53 g/24h, 5 (35%) had nephrotic syndrome, and 2 had gross haematuria. All patients presented renal dysfunction with a high level of Scr 498.6±288.6umol/l, and 7 patients required initial renal replacement therapy. Renal biopsy showed paci-immune segmental necrotizing glomerulonephritis with crescent formation in 13 patients (6 mixed class, 4 crescentic class, 2 focal class, and one sclerotic class), and acute interstitial nephritis in one. 12 patients (85.7%) had eosinophil infiltration in renal interstitium, and 3 showed eosinophil granuloma. All patients received corticosteroid with immunosuppressant therapy. 5 patients of those who required initial renal replacement therapy got rid of dialysis, one entered maintenance hemodialysis, and one died. 12 patients were followed up for 6 to 83 months (median 43.5), 2 patients were in completely remission ( normal renal function and urine analysis), 9 progressed to chronic renal failure, one developed to ESRD and one had extra-renal relapse. Conclusion: The renal involvement of eosinophilic granulomatosis with polyangiitis was severe and the renal histological lesions were diverse. Aggressive immunosuppressive therapy could effectively improve renal function, but the overall renal prognosis was poor. Early diagnosis and treatment were needed to improve the long-term renal survival.

Key words:  eosinophilic granulomatosis with polyangiitis, renal damage,   antineutrophil cytoplasmic antibody , antineutrophil cytoplasmic antibody associated vasculitis